SCHEMBL6840099

SCHEMBL6840099

FC(F)(F)c1nc2ccccc2c2c1nc(-c1ncc[nH]1)n2CCC1CCNCC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 2/20 0.37
HTR4 Q13639 1/20 0.36
KCNK13 Q9HB14 1/20 0.36
ACP1 P24666 6/20 0.35
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
MERTK Q12866 1/20 0.33
PDGFRB P09619 1/20 0.32
FGFR1 P11362 1/20 0.32
KDR P35968 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
ADRB2 P07550 1/20 0.31
NR3C1 P04150 1/20 0.31
SLC6A4 P31645 2/20 0.31
KHK P50053 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833773 0.89 NPY1R (0.37) NPY1RKCNK13ACP1JAK2JAK1
SCHEMBL6838709 0.89 CCR3 (0.33) NPY1RJAK2JAK1TYK2JAK3
SCHEMBL6838737 0.89 JAK2 (0.32) NPY1RJAK2JAK1TYK2JAK3
SCHEMBL6929821 0.88 HTR4 (0.40) NPY1RHTR4KCNK13ACP1JAK2
SCHEMBL6838635 0.88 NPY1R (0.37) NPY1RJAK2JAK1TYK2JAK3
SCHEMBL6925994 0.87 NPY1R (0.42) NPY1RHTR4KCNK13ACP1JAK2
SCHEMBL6833713 0.86 NPY1R (0.39) NPY1RHTR4ACP1TLR7MERTK
SCHEMBL6838715 0.85 ACP1 (0.37) NPY1RHTR4ACP1TLR7MERTK
SCHEMBL6838657 0.83 NPY1R (0.36) NPY1RHTR4ACP1TLR7MERTK
SCHEMBL6838577 0.83 PDE6D (0.37) NPY1RHTR4ACP1TLR7MERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 NPY1R 1070/4885HTR4 2764/4885KCNK13 1759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.